油酰肌氨酸 | 110-25-8

• 物质功能分类: 生物化工 - 常见氨基酸及蛋白质类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 油酰肌氨酸
• 中文别名: N-油酰肌氨酸
• 英文名称: N-oleoylsarcosine
• 英文别名: oleoyl sarcosine；2-[methyl-[(Z)-octadec-9-enoyl]amino]acetic acid
• CAS: 110-25-8
• 化学式: C₂₁H₃₉NO₃
• 分子量: 353.546
• InChiKey: DIOYAVUHUXAUPX-KHPPLWFESA-N

物化性质

• 熔点：
  16.1-17.0℃
• 沸点：
  499.4±38.0 °C(Predicted)
• 密度：
  0.961
• 闪点：
  221°C
• LogP：
  6.998 (est)
• 物理描述：
  Liquid

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  25
• 可旋转键数：
  17
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  57.6
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2924199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

制备方法与用途

用途：用作高效的缓蚀剂。

反应信息

• 作为反应物：
  描述：

  二乙二醇单甲醚 、 油酰肌氨酸 在 Amberlyst 15 acidic resin 作用下， 反应 3.0h， 以273.5 g的产率得到oleoyl 2-methoxyethyl sarcosinate
  参考文献：
  名称：

  Additive compositions with a friction modifier and a detergent

  摘要：

  一种润滑组合物，包含主要成分为基础油和少量添加剂包，其中添加剂包括(A)摩擦改性剂组分，选自：(a)醇与化合物IV的反应产物之一或多个：和(b)化合物II-III之一或多个：其中R是具有大约8到22个碳原子的线性或支链、饱和、不饱和或部分饱和的烃基；R2和R3分别选自氢、C1-C18烃基团和含有一个或多个杂原子的C1-C18烃基团；X是碱金属、碱土金属或铵阳离子，n是阳离子X的价；以及(B)至少一种清净剂。

  公开号：

  US09499762B2
• 作为产物：
  描述：

  油酰氯 在 N,N-二异丙基乙胺 、 lithium hydroxide 作用下， 以 甲醇 、 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 12.0h， 生成 油酰肌氨酸
  参考文献：
  名称：

  Design and Synthesis of Lipids for the Fabrication of Functional Lipidic Cubic-Phase Biomaterials

  摘要：

  A series of novel lipids with designed functionalities were synthesized. These lipids are based on conjugation of alpha-amino acids and their esters, cationic, anionic, neutral, and photochromic moieties to the lipophilic 9-cis octadecenyl chains by amide, ester, thioester, or amine bonds. Because of the plasticity of lipidic cubic phases, it is envisaged that when mixed with monooleoyl-rac-glycerol (monoolein, MO) and water at appropriate proportions, they would assemble to form bicontinuous lipidic cubic phases (LCPs) that exhibit the well-known material properties of LCPs such as phase stability, optical transparency, and chemical permeability. Moreover, due to the nature and position of the functionality at the headgroup region, we envision them to perform as functional materials by design.

  DOI：

  10.1021/jo301659c

文献信息

• N-Allyl/benzyl substituted phenylenediamine stabilizers
  申请人：CIBA-GEIGY AG

  公开号：EP0538195A2

  公开（公告）日：1993-04-21

  Compositions are described which comprise (a) a lubricant, subject to oxidative or thermal degradation, and (b) at least one compound of formula I wherein    R⁵, R⁶, R⁷ and R⁸ are independently hydrogen, alkenyl of 3 to 18 carbon atoms, aralkyl of 7 to 15 carbon atoms, aryl of 6 to 10 carbon atoms or said aryl substituted by one to three substituents selected from the group consisting of alkyl of 1 to 20 carbon atoms, cycloalkyl of 5 to 12 carbon atoms, aralkyl of 7 to 15 carbon atoms, -CN, -NO⁶, halogen, -ORψ, -NR¼R½, -SR¾, -COOR| and -CONR⁵⁴R⁵⁵ where Rψ, R¼, R½, R¾, R|, R⁵⁴ and R⁵⁵ are independently hydrogen, alkyl of 1 to 20 carbon atoms, alkenyl of 3 to 18 carbon atoms, aryl of 6 to 10 carbon atoms, cycloalkyl of 5 to 12 carbon atoms or aralkyl of 7 to 15 carbon atoms. Some of the compounds of formula one are novel.

  描述了以下组成的组合物： (a) 一种润滑剂，容易受到氧化或热降解，和 (b) 至少一个公式 I 的化合物 其中 R⁵, R⁶, R⁷ 和 R⁸ 分别独立为氢，3至18碳原子的烯基，7至15碳原子的芳基烷基，6至10碳原子的芳基或所述芳基被1至3个选自以下组的取代基所取代：1至20碳原子的烷基，5至12碳原子的环烷基，7至15碳原子的芳基烷基，-CN, -NO⁶, 卤素，-ORψ, -NR¼R½, -SR¾, -COOR| 和 -CONR⁵⁴R⁵⁵，其中 Rψ, R¼, R½, R¾, R|, R⁵⁴ 和 R⁵⁵ 分别独立为氢，1至20碳原子的烷基，3至18碳原子的烯基，6至10碳原子的芳基，5至12碳原子的环烷基或7至15碳原子的芳基烷基。 公式 I 中的某些化合物是新颖的。
• BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
  申请人：SENOMYX, INC.

  公开号：US20160376263A1

  公开（公告）日：2016-12-29

  The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.

  本发明涵盖已知用于改变苦味感知的化合物和组合物，以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种：冷却剂；无活性药物成分；活性药用成分；食品添加剂或食品；调味剂或调味增强剂；食品或饮料产品；苦味化合物；甜味剂；苦味剂；酸味调味剂；咸味调味剂；鲜味调味剂；植物或动物产品；已知用于宠物护理产品中的化合物；已知用于个人护理产品中的化合物；已知用于家用产品中的化合物；制药制剂；局部制剂；大麻衍生或与大麻相关的产品；已知用于口腔护理产品中的化合物；饮料；香味、香水或除臭剂；已知用于消费品中的化合物；硅化合物；磨料；表面活性剂；发热剂；吸烟物品；脂肪、油脂或乳化剂；和/或益生菌或补充剂。
• SKIN EXTERNAL PREPARATIONS AND COSMETICS
  申请人：Aoki Hirobumi

  公开号：US20100280111A1

  公开（公告）日：2010-11-04

  An object of the present invention is to provide skin external preparations and cosmetics which contain a branched acyl carnitine and have excellent formulation stability. A skin external preparation of the present invention includes a carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and an amphoteric surfactant. In Formula (1), R 1 and R 2 are each independently a C1-18 optionally branched, saturated or unsaturated aliphatic hydrocarbon group. In Formula (2), R 1 and R 2 are the same as in Formula (1), X − is a specific anion and Y + is a specific cation.

  本发明的一个目的是提供含有支链酰基肉碱并具有优异配方稳定性的皮肤外用制剂和化妆品。本发明的皮肤外用制剂包括以下式（1）所表示的肉碱衍生物和/或以下式（2）所表示的肉碱衍生物盐，以及一种两性表面活性剂。在式（1）中，R1和R2分别独立地是C1-18的可选支链、饱和或不饱和脂肪烃基。在式（2）中，R1和R2与式（1）中相同，X−是特定的阴离子，Y+是特定的阳离子。
• METHODS, COMPOSITIONS, AND FORMULATIONS FOR PREVENTING OR REDUCING ADVERSE EFFECTS IN A PATIENT
  申请人：Stover Richard R.

  公开号：US20080175891A1

  公开（公告）日：2008-07-24

  The present invention provides transdermal administration of AICA riboside, or a prodrugs, analogs, or salts thereof, and/or a blood clotting inhibitor for preventing or reducing adverse side effects in a patient. The type of patient that may benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient undergoing non-vascular surgery, or a fetus during labor and delivery.

  本发明提供了通过经皮途径给予AICA核糖苷，或其前药、类似物或盐，和/或血液凝块抑制剂以预防或减少患者的不良副作用。可能受益的患者类型包括左心室功能减退的患者、先前发生心肌梗死的患者、接受非血管手术的患者，或分娩期间的胎儿。
• Method for the production of alkyl aryl sulphonates
  申请人：——

  公开号：US20040030209A1

  公开（公告）日：2004-02-12

  The preparation of alkylaryl compounds takes place by 1) preparation of a mixture of, on statistical average, predominantly monobranched C 10-14 -olefins by a) reaction of a C 4 -olefin mixture over a metathesis catalyst for the preparation of an olefin mixture comprising 2-pentene and/or 3-hexene, and optional removal of 2-pentene and/or 3-hexene, followed by dimerization of the resulting 2-pentene and/or 3-hexene over a dimerization catalyst to give a mixture comprising C 10-12 -olefins, and optionally removal of the C 10-12 -olefins, or b) extraction of predominantly monobranched paraffins from kerosene cuts and subsequent dehydrogenation, or c) Fischer-Tropsch synthesis of olefins or paraffins, where the paraffins are dehydrogenated, or d) dimerization of shorter-chain internal olefins, or e) isomerization of linear olefins or paraffins, where the isomerized paraffins are dehydrogenated, 2) reaction of the olefin mixture obtained in stage 1) with an aromatic hydrocarbon in the presence of an alkylation catalyst which contains zeolites of the faujasite type.

  烷基芳烃化合物的制备通过以下步骤进行：1）制备主要为单支链C10-14烯烃的混合物，方法包括a）将C4烯烃混合物与交换催化剂反应，制备包含2-戊烯和/或3-己烯的烯烃混合物，可选择性去除2-戊烯和/或3-己烯，然后将所得的2-戊烯和/或3-己烯在二聚化催化剂作用下二聚化，得到包含C10-12烯烃的混合物，可选择性去除C10-12烯烃；b）从煤油馏分中提取主要为单支链的烷烃，随后进行脱氢；c）费舍尔-特罗普合成烯烃或烷烃，其中烷烃进行脱氢；d）较短链内部烯烃的二聚化；e）线性烯烃或烷烃的异构化，其中异构化的烷烃进行脱氢；2）将第1步得到的烯烃混合物与芳香烃在烷基化催化剂存在下反应，该催化剂含有沸石型沸石。